Related Experiment Video
Updated: Aug 6, 2025
09:01
Intraportal Transplantation of Pancreatic Islets in Mouse Model
Published on: May 5, 2018
9.6K
Intravenous Insulin in Hypertriglyceridemic Pancreatitis
Goolla Akhila1, Ipsita Sahoo2, Debashree Priyadarshini1
1Department of Pediatrics, IMS & SUM Hospital, Bhubaneswar, Odisha, 751003, India.
Indian Journal of Pediatrics
|March 23, 2023
Summary
Severe hypertriglyceridemia can cause pancreatitis in children. Intravenous insulin effectively managed a child
Area of Science:
- Pediatric Gastroenterology
- Endocrinology
- Critical Care Medicine
Background:
- Hypertriglyceridemia is a rare but serious cause of pancreatitis in children.
- Hypertriglyceridemic pancreatitis is associated with increased severity and complications, including pancreatic necrosis.
Observation:
- This report details a case of pediatric hypertriglyceridemic pancreatitis.
- The child patient was successfully treated with intravenous insulin.
Findings:
- Intravenous insulin demonstrated high efficacy in managing severe hypertriglyceridemia-induced pancreatitis in this pediatric case.
- This aligns with findings in adult cases and limited pediatric reports involving diabetic ketoacidosis.
Implications:
- Intravenous insulin is a viable and effective treatment option for hypertriglyceridemic pancreatitis in children.
- This approach may help prevent severe complications and recurrent episodes in pediatric patients.
Related Concept Videos
01:30Acute Pancreatitis II: Clinical Manifestations and Management
162
Acute pancreatitis presents a complex medical emergency characterized by rapid onset inflammation of the pancreas, demanding timely diagnosis and management to prevent complications. The condition primarily manifests through severe upper abdominal pain that often radiates to the back. This pain intensifies following the consumption of fatty foods. Accompanying symptoms such as nausea, vomiting, abdominal distention, fever, dyspnea, cyanosis, and jaundice can vary in intensity but significantly...
162
01:16Insulin: Dosing Regimen and Adverse Effects
220
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
220
01:27Acute Pancreatitis I: Introduction
431
Pancreatitis is inflammation of the pancreas, an organ located behind the stomach. It can be either acute or chronic.
Acute pancreatitis is characterized by rapid inflammation of the pancreas, often caused by factors like gallstone blockage or excessive alcohol consumption. Chronic pancreatitis, on the other hand, is a slow, progressive inflammation that may result from long-term alcohol abuse, obstructions in the pancreatic duct, or genetic factors.
The causes of acute pancreatitis include:
Acute pancreatitis is characterized by rapid inflammation of the pancreas, often caused by factors like gallstone blockage or excessive alcohol consumption. Chronic pancreatitis, on the other hand, is a slow, progressive inflammation that may result from long-term alcohol abuse, obstructions in the pancreatic duct, or genetic factors.
The causes of acute pancreatitis include:
431
01:29Chronic Pancreatitis II: Collaborative Care
121
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
121
01:23Dipeptidyl Peptidase 4 Inhibitors
222
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
222
01:27Insulin Formulations: Types and Delivery
242
Insulin preparations are categorized by their duration of action into short-acting and long-acting types. Two strategies are used to modify insulin's absorption and pharmacokinetic profile: slowing the absorption post-subcutaneous injection, or altering human insulin's amino acid sequence or protein structure. These changes retain the insulin's ability to bind to the insulin receptor, but alter its behavior in solution or after injection.
Short-acting insulins are divided into...
Short-acting insulins are divided into...
242